The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Xencor
Stock and Other Ownership Interests - Xencor
Consulting or Advisory Role - Aclaris Therapeutics; Chameleon Pharma Consulting; Leap Oncology
Patents, Royalties, Other Intellectual Property - Aclaris,; Xencor
Preliminary safety and pharmacodynamic (PD) activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in a phase I dose escalation study of patients with selected advanced solid tumors.
 
Barbara Hickingbottom
Employment - Xencor
Stock and Other Ownership Interests - Xencor
 
Raphael Clynes
No Relationships to Disclose
 
John Desjarlais
Employment - Xencor
Leadership - Xencor
Stock and Other Ownership Interests - Xencor
Consulting or Advisory Role - Abexxa Biologics
Research Funding - MustangBio (I)
Patents, Royalties, Other Intellectual Property - City of Hope Mustang Bio (I)
 
Caiyan Li
Employment - Xencor
Leadership - Xencor
Stock and Other Ownership Interests - Xencor
 
Ying Ding
Employment - Xencor
Stock and Other Ownership Interests - Xencor